靶向巨细胞病毒筛查背景下先天性双侧听力损失的基因检测
该研究基于OtoSCOPE数据库回顾性分析2012至2019年接受全面基因检测的听力损失患者,评估先天性双侧听力损失患儿中遗传与巨细胞病毒(CMV)病因的比例。
要点
- CMV阳性听力损失新生儿中约2%存在已知遗传变异。
- CMV阳性伴对称性轻中度双侧听力损失者遗传变异概率至少7%。
核心结论
- 约2%的CMV阳性听力损失新生儿携带已知遗传变异作为病因。
- CMV阳性且对称性轻中度双侧听力损失新生儿携带致病基因变异概率至少7%。
- 双侧新生儿听力筛查未通过的CMV阳性新生儿应考虑基因筛查以准确诊断并可能推迟抗病毒治疗。
研究设计与样本
- 数据库回顾性研究,审查2012年1月至2019年1月接受全面基因检测的听力损失患者临床检测结果。
- OtoSCOPE数据库中4282例患者有CMV状态记录,其中661例记录为双侧先天性听力损失。
主要发现
- 4282例患者中61例有记录的CMV状态,661例有记录的双侧先天性听力损失。
- 2例患者同时有CMV阳性结果和听力损失的遗传病因。
- 320例遗传病因患者中62%(198/320)的听力损失与GJB2、STRC、SLC26A4或Usher综合征相关基因的致病变异相关。
关键数值与推荐
- CMV阳性听力损失新生儿中约2%具有已知遗传变异作为病因。
- CMV阳性且对称性轻中度双侧听力损失新生儿亚组携带听力损失相关致病基因变异的概率至少7%。
临床怎么用
- 对CMV阳性且双侧新生儿听力筛查未通过的新生儿,应考虑基因筛查以准确诊断并可能推迟抗病毒治疗。
局限性
- 证据级别为4级。
- 研究为数据库回顾性审查,仅61/4282例患者有记录的CMV状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To determine the prevalence of children with genetic hearing loss who are cytomegalovirus (CMV) positive at birth and the relative proportion of genetic and CMV etiology among children with congenital bilateral hearing loss. STUDY DESIGN: Database review. METHODS: We performed a review of clinical test results for patients undergoing comprehensive genetic testing for all known hearing loss-associated genes from January 2012 to January 2019. This population was reviewed for reported CMV status and genetic causes of congenital bilateral hearing loss. RESULTS: In the OtoSCOPE database, 61/4,282 patients were found to have a documented CMV status, and 661/4282 had documented bilateral congenital hearing loss. Two patients were identified who had both a positive CMV result and a genetic cause for their hearing loss. Forty-eight percent of patients with bilateral congenital hearing loss (320/661) were found to have a genetic etiology. In 62% (198/320), the hearing loss was associated with pathogenic variants in GJB2, STRC, SLC26A4 or an Usher syndrome-associated gene. CONCLUSIONS: We estimate that ~2% of CMV-positive newborns with hearing loss have a known genetic variant as a cause. The subcohort of CMV-positive newborns with symmetric mild-to-moderate bilateral hearing loss will have at least a 7% chance of having pathogenic gene variants associated with hearing loss. In a CMV-positive neonate who failed their newborn hearing screen bilaterally, genetic screening needs to be considered for accurate diagnosis and possible deferment of antiviral treatment. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:2714-2718, 2020.
引用
- Peterson J, Nishimura C, Smith RJH, et al. Genetic Testing for Congenital Bilateral Hearing Loss in the Context of Targeted Cytomegalovirus Screening. Laryngoscope. 2020. PMID: 31985074. doi:10.1002/lary.28536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。